Viewray Inc (NASDAQ:VRAY) – Analysts at Piper Jaffray Companies issued their Q2 2019 earnings per share estimates for Viewray in a research report issued to clients and investors on Tuesday, June 18th, Zacks Investment Research reports. Piper Jaffray Companies analyst M. O’brien expects that the company will post earnings per share of ($0.17) for the quarter. Piper Jaffray Companies currently has a “Overweight” rating and a $15.00 price objective on the stock. Piper Jaffray Companies also issued estimates for Viewray’s Q3 2019 earnings at ($0.20) EPS, Q4 2019 earnings at ($0.19) EPS, FY2019 earnings at ($0.91) EPS, Q1 2020 earnings at ($0.16) EPS, Q2 2020 earnings at ($0.13) EPS, Q3 2020 earnings at ($0.12) EPS, Q4 2020 earnings at ($0.10) EPS, FY2020 earnings at ($0.51) EPS, FY2021 earnings at ($0.32) EPS and FY2022 earnings at ($0.11) EPS.
Other research analysts also recently issued research reports about the stock. TheStreet downgraded shares of Viewray from a “c-” rating to a “d” rating in a report on Friday, May 3rd. ValuEngine downgraded shares of Zumiez from a “hold” rating to a “sell” rating in a report on Monday, May 13th. BidaskClub downgraded shares of Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Wednesday, June 26th. Zacks Investment Research upgraded shares of SCHNEIDER ELEC /ADR from a “hold” rating to a “buy” rating and set a $20.00 price target on the stock in a report on Friday, July 5th. Finally, Cantor Fitzgerald set a $13.00 price target on shares of Viewray and gave the company a “buy” rating in a report on Tuesday, May 28th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Viewray has an average rating of “Buy” and a consensus target price of $13.05.
VRAY stock traded down $0.02 during midday trading on Thursday, reaching $9.17. The company had a trading volume of 698,264 shares, compared to its average volume of 821,755. The stock has a market capitalization of $889.06 million, a P/E ratio of -9.36 and a beta of 0.79. The company’s 50 day moving average price is $8.67. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.28 and a quick ratio of 3.21. Viewray has a 1 year low of $4.86 and a 1 year high of $13.21.
Viewray (NASDAQ:VRAY) last released its earnings results on Thursday, May 2nd. The company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.12). Viewray had a negative return on equity of 71.16% and a negative net margin of 139.82%. The company had revenue of $20.30 million during the quarter, compared to analysts’ expectations of $20.40 million. During the same quarter in the previous year, the company earned ($0.11) EPS. The firm’s quarterly revenue was down 22.5% compared to the same quarter last year.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Marshall Wace LLP grew its position in Viewray by 47.1% in the 1st quarter. Marshall Wace LLP now owns 131,179 shares of the company’s stock worth $970,000 after purchasing an additional 42,015 shares during the last quarter. Candriam Luxembourg S.C.A. grew its position in Viewray by 1,204.8% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 132,857 shares of the company’s stock worth $982,000 after purchasing an additional 122,675 shares during the last quarter. Northern Trust Corp grew its position in Viewray by 2.7% in the 4th quarter. Northern Trust Corp now owns 836,280 shares of the company’s stock worth $5,077,000 after purchasing an additional 22,187 shares during the last quarter. Penn Capital Management Co. Inc. grew its position in Viewray by 6.0% in the 1st quarter. Penn Capital Management Co. Inc. now owns 554,892 shares of the company’s stock worth $4,101,000 after purchasing an additional 31,327 shares during the last quarter. Finally, Prescott Group Capital Management L.L.C. grew its position in Viewray by 1,141.9% in the 4th quarter. Prescott Group Capital Management L.L.C. now owns 200,476 shares of the company’s stock worth $1,217,000 after purchasing an additional 184,333 shares during the last quarter.
In related news, insider James F. Dempsey sold 5,146 shares of Viewray stock in a transaction on Monday, July 1st. The shares were sold at an average price of $8.63, for a total value of $44,409.98. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 15.48% of the company’s stock.
Viewray Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.